| MINOR SPONSORS’ SYMPOSIA |
| Wednesday, April 13, 2005 |
| 19:00-20:00 |
|
| |
| Thursday, April 14, 2005 |
| 12:30-13:30 |
Symposium organised by |
| Abbott |
Salon Concorde # 1 |
HOST AND VIRAL GENOMES: KEY DETERMINANTS OF PATIENT MANAGEMENT IN CHRONIC VIRAL HEPATITIS |
| |
Symposium organised by |
| Bracco |
Salon Concorde # 2 |
ADVANCES IN DIAGNOSTIC IMAGING: THE VALUE OF CONTRAST-ENHANCED ULTRASOUND FOR LIVER |
| |
Symposium organised by |
| GlaxoSmithKline |
Amphitheatre Bleu |
PREVENTING DISEASE PROGRESSION IN CHRONIC HEPATITIS B |
| |
Symposium organised by |
| SciClone Pharmaceuticals, Inc |
242AB |
THERAPEUTIC STRATEGIES FOR DIFFICULT TO TREAT HBV AND HCV PATIENT GROUPS: TREATMENT REGIMENS USING THYMALFASIN, AN IMMUNE SYSTEM ENHANCER |
| |
Symposium organised by |
| Valeant Pharmaceuticals International |
252AB |
AN UPDATE ON RIBAVIRIN ANALOGUES: MEETING THE CHALLENGE OF ANEMIA IN HEPATITIS C TREATMENT |
| |
| |
| MAJOR SPONSORS’ SYMPOSIA |
| Thursday,
April 14, 2005 |
| 18:00-19:30 |
Satellite Symposium organized by: |
| Gilead Sciences |
Grand Amphitheatre |
CHRONIC HEPATITIS B: A NEW LOOK AT THE FUTURE |
| |
| Friday, April
15, 2005 |
| 08:30-10:00 |
Satellite Symposium organized by: |
| Schering-Plough Pharmaceuticals |
Grand Amphitheatre |
FROM PROTEIN TO PATIENT: TARGETED STRATEGIES TO MAXIMIZE THERAPEUTIC RESPONSES IN HCV |
| |
| Saturday,
April 16, 2005 |
| 08:30-10:00 |
Satellite Symposium organized by: |
| Bristol Meyers Squibb |
Amphitheatre Bleu |
Time to act in Hepatitis B |
| 18:00-19:30 |
| Satellite Symposium organized by: |
| Roche |
Grand Amphitheatre |
VIVE LA DIFFÉRENCE - MEETING THE CHALLENGE OF PATIENT DIVERSITY IN HEPATITIS C |
| |
| Sunday, April 17, 2005 |
| 08:30-10:00 |
Satellite Symposium organized by: |
Idenix / Novartis |
Amphitheatre Bleu |
| OPTIMIZING CLINICAL OUTCOMES IN HEPATITIS B: NEW DIRECTIONS FOR PATIENT MANAGEMENT |
